Invested in Hoba Therapeutics' EUR 23M Series A.
Hoba Therapeutics is a Danish biotech developing restorative treatments for chronic pain disorders and hearing loss
Hoba Therapeutics is a Danish biotech developing restorative treatments for chronic pain disorders and hearing loss. The company is focused on developing non-opioid compounds targeting the peripheral nervous system to reverse neuropathic pain and treat sensorineural hearing loss.